EMAIL THIS PAGE TO A FRIEND

Diabetes care

Increased fructose concentrations in blood and urine in patients with diabetes.


PMID 11815509

Abstract

To investigate fructose metabolic changes in patients with diabetes. Serum and urinary fructose concentrations were determined in healthy subjects (n = 23) and in nondiabetic (n = 23) and diabetic patients (n = 26). Fructose was measured using our newly developed method, and (13)C(6)-fructose was used as the internal standard. After adding sample to a fixed amount of internal standard, ion-exchange resins and high-performance liquid chromatography pretreatments were performed. Then, the amount of fructose in the sample was measured by gas chromatography-mass spectrometry. Serum fructose concentrations in patients with diabetes (12.0 +/- 3.8 micromol/l) were significantly higher than those in healthy subjects (8.1 +/- 1.0 micromol/l, P < 0.001) and nondiabetic patients (7.7 +/- 1.6 micromol/l, P < 0.001), and daily urinary fructose excretion was significantly greater in patients with diabetes (127.8 +/- 106.7 micromol/day) than in nondiabetic patients (37.7 +/- 23.0 micromol/day, P < 0.001). In patients with diabetes (n = 20), serum fructose concentrations (8.6 +/- 1.8 micromol/l, P < 0.001) and daily urinary fructose excretion (63.4 +/- 63.8 micromol/day, P < 0.01) significantly decreased by week 2 after admission. The present results differed from those of previous studies in that we found that the serum and urinary fructose concentrations decreased rapidly, concomitant with an improvement in glycemia. Therefore, hyperglycemia was associated with increased serum and urinary fructose concentrations in patients with diabetes.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

54920
(R)-3-Hydroxybutyric acid, ≥98.0% (T)
C4H8O3
34867
1-Butanol, for HPLC, ≥99.7%
C4H10O
360465
1-Butanol, ACS reagent, ≥99.4%
C4H10O
33065
1-Butanol, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.5% (GC)
C4H10O
537993
1-Butanol, 99.9%
C4H10O
901351
1-Butanol, BioRenewable, ACS reagent, ≥99.4%
C4H10O
67520
1-Methyl-L-histidine, ≥98.0% (TLC)
C7H11N3O2
166898
3-Hydroxybutyric acid, 95%
C4H8O3
M9005
3-Methyl-L-histidine
C7H11N3O2
46204
4-Heptanone, analytical standard
C7H14O
W254606
4-Heptanone, ≥97%, FG
C7H14O
101745
4-Heptanone, 98%
C7H14O
650501
Acetone, HPLC Plus, for HPLC, GC, and residue analysis, ≥99.9%
C3H6O
270725
Acetone, for HPLC, ≥99.9%
C3H6O
34850
Acetone, for HPLC, ≥99.8%
C3H6O
179124
Acetone, ACS reagent, ≥99.5%
C3H6O
320110
Acetone, ACS reagent, ≥99.5%
C3H6O
534064
Acetone, histological grade, ≥99.5%
C3H6O
32201
Acetone, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.5% (GC)
C3H6O
24201
Acetone, puriss., meets analytical specification of Ph. Eur., BP, NF, ≥99% (GC)
C3H6O
179973
Acetone, Laboratory Reagent, ≥99.5%
C3H6O
44892-U
ASTM® D6584 Glycerin solution, 500 μg/mL in pyridine, analytical standard
C3H8O3 · xH2O
27066
Chromium, coating quality, 99.95%, grit
Cr
374849
Chromium, chips, 99.995% trace metals basis
Cr
255610
Chromium, chips, thickness ~2 mm, 99.5%
Cr
266264
Chromium, powder, 99.5%, −100 mesh
Cr
266299
Chromium, powder, ≥99% trace metals basis, <45 μm
Cr
749052
Chromium, sputtering target, diam. × thickness 3.00 in. × 0.125 in., 99.95% trace metals basis
Cr
L0625
D-(−)-Lactic acid, ≥90%
C3H6O3
295280
Dimethylamine, anhydrous, ≥99%
C2H7N